104 related articles for article (PubMed ID: 10348255)
1. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
Capizzi RL
Semin Oncol; 1999 Apr; 26(2 Suppl 7):3-21. PubMed ID: 10348255
[TBL] [Abstract][Full Text] [Related]
2. Amifostine Prophylaxis in Irradiated Breast Reconstruction: A Study of Oncologic Safety In Vitro.
Luby AO; Subramanian C; Buchman LK; Lynn JV; Urlaub KM; Nelson NS; Donneys A; Cohen MS; Buchman SR
Ann Plast Surg; 2020 Oct; 85(4):424-429. PubMed ID: 31850964
[TBL] [Abstract][Full Text] [Related]
3. A novel multifunctional radioprotective strategy using P7C3 as a countermeasure against ionizing radiation-induced bone loss.
Wei F; Tuong ZK; Omer M; Ngo C; Asiatico J; Kinzel M; Pugazhendhi AS; Khaled AR; Ghosh R; Coathup M
Bone Res; 2023 Jun; 11(1):34. PubMed ID: 37385982
[TBL] [Abstract][Full Text] [Related]
4. Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease.
Ma B; Li T; Li W; Yang H; Zeng Q; Pan Z; Wang K; Chen Q; Xiong C; Zhou Z
Stem Cell Reports; 2022 Dec; 17(12):2674-2689. PubMed ID: 36400028
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Tissue Metabolite Profiles with Amifostine-Prophylaxed Mice Exposed to Gamma Radiation.
Cheema AK; Li Y; Girgis M; Jayatilake M; Fatanmi OO; Wise SY; Seed TM; Singh VK
Metabolites; 2020 May; 10(5):. PubMed ID: 32455594
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats.
Jaćević V; Dragojević-Simić V; Tatomirović Ž; Dobrić S; Bokonjić D; Kovačević A; Nepovimova E; Vališ M; Kuča K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103540
[TBL] [Abstract][Full Text] [Related]
7. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis.
Seed TM; Inal CE; Singh VK
Int J Radiat Biol; 2014 Jul; 90(7):594-604. PubMed ID: 24597748
[TBL] [Abstract][Full Text] [Related]
8. Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).
Yazbeck VY; Villaruz L; Haley M; Socinski MA
Cancer J; 2013; 19(3):231-7. PubMed ID: 23708070
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of amifostine for the management of oral mucositis in cancer patients.
Nicolatou-Galitis O; Sarri T; Bowen J; Di Palma M; Kouloulias VE; Niscola P; Riesenbeck D; Stokman M; Tissing W; Yeoh E; Elad S; Lalla RV;
Support Care Cancer; 2013 Jan; 21(1):357-64. PubMed ID: 23052919
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of amifostine on ultraviolet B-exposed xeroderma pigmentosum mice.
Henry S; Christiansen D; Kazmier F; Besch-Williford C; Concannon M
Ecancermedicalscience; 2010; 4():176. PubMed ID: 22276030
[TBL] [Abstract][Full Text] [Related]
11. The radioprotective agent WR1065 protects cells from radiation damage by regulating the activity of the Tip60 acetyltransferase.
Xu Y; Parmar K; Du F; Price BD; Sun Y
Int J Biochem Mol Biol; 2011; 2(4):295-302. PubMed ID: 22187663
[TBL] [Abstract][Full Text] [Related]
12. Redox platforms in cancer drug discovery and development.
Tew KD; Townsend DM
Curr Opin Chem Biol; 2011 Feb; 15(1):156-61. PubMed ID: 21075043
[TBL] [Abstract][Full Text] [Related]
13. The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies.
Grek CL; Townsend DM; Tew KD
Pharmacol Ther; 2011 Feb; 129(2):172-84. PubMed ID: 20951732
[TBL] [Abstract][Full Text] [Related]
14. Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.
Ma C; Xie J; Jiang Z; Wang G; Zuo S
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1778-85. PubMed ID: 20130857
[TBL] [Abstract][Full Text] [Related]
15. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
Ma C; Xie J; Chen Q; Wang G; Zuo S
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007956. PubMed ID: 19821441
[TBL] [Abstract][Full Text] [Related]
16. Use of amifostine in the treatment of recurrent solid tumours in children.
Sidi V; Arsos G; Papakonstantinou E; Hatzipantelis E; Fragandrea I; Gombakis N; Koliouskas E
Hippokratia; 2007 Jan; 11(1):25-9. PubMed ID: 19582173
[TBL] [Abstract][Full Text] [Related]
17. Dietary essential fatty acids and gender-specific behavioral responses in cranially irradiated rats.
Elkin TD; Wollan MO; Anderson SL; Gaston R; Meyer W; Fuemmeler BF; Holloway FA; Martin RE
Neuropsychiatr Dis Treat; 2006 Sep; 2(3):365-74. PubMed ID: 19412484
[TBL] [Abstract][Full Text] [Related]
18. Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
Fouladi M; Chintagumpala M; Ashley D; Kellie S; Gururangan S; Hassall T; Gronewold L; Stewart CF; Wallace D; Broniscer A; Hale GA; Kasow KA; Merchant TE; Morris B; Krasin M; Kun LE; Boyett JM; Gajjar A
J Clin Oncol; 2008 Aug; 26(22):3749-55. PubMed ID: 18669462
[TBL] [Abstract][Full Text] [Related]
19. Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
Rolleman EJ; Forrer F; Bernard B; Bijster M; Vermeij M; Valkema R; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):763-771. PubMed ID: 17146655
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
